108 related articles for article (PubMed ID: 2114954)
1. Serum bactericidal activity from intravenous ciprofloxacin and azlocillin given alone and in combination to healthy subjects.
Orlando PL; Barriere SL; Hindler JA; Frost RW
Diagn Microbiol Infect Dis; 1990; 13(2):93-7. PubMed ID: 2114954
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods.
Moody JA; Gerding DN; Peterson LR
Am J Med; 1987 Apr; 82(4A):44-54. PubMed ID: 3107380
[TBL] [Abstract][Full Text] [Related]
3. Synergy of ciprofloxacin and azlocillin in vitro and in a neutropenic mouse model of infection.
Chin NX; Jules K; Neu HC
Eur J Clin Microbiol; 1986 Feb; 5(1):23-8. PubMed ID: 2938945
[TBL] [Abstract][Full Text] [Related]
4. Bactericidal activity of ciprofloxacin alone and in combination with azlocillin in an in-vitro capillary model.
Zinner SH; Dudley MN
J Antimicrob Chemother; 1986 Nov; 18 Suppl D():49-54. PubMed ID: 3100491
[TBL] [Abstract][Full Text] [Related]
5. Ciprofloxacin, azlocillin, ceftizoxime and amikacin alone and in combination against gram-negative bacilli in an infected chamber model.
Bamberger DM; Peterson LR; Gerding DN; Moody JA; Fasching CE
J Antimicrob Chemother; 1986 Jul; 18(1):51-63. PubMed ID: 3093445
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of ciprofloxacin alone and in combination with azlocillin in experimental endocarditis due to Pseudomonas aeruginosa.
Thauvin C; Lecomte F; Le Boete I; Grise G; Lemeland JF
Infection; 1989; 17(1):31-4. PubMed ID: 2493429
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy with ciprofloxacin plus azlocillin against Pseudomonas aeruginosa: effect of simultaneous versus staggered administration in an in vitro model of infection.
Dudley MN; Blaser J; Gilbert D; Mayer KH; Zinner SH
J Infect Dis; 1991 Sep; 164(3):499-506. PubMed ID: 1908000
[TBL] [Abstract][Full Text] [Related]
8. Comparative in-vitro activities of azlocillin, ticarcillin and ticarcillin plus clavulanic acid against Staphylococcus aureus, Klebsiella pneumoniae and Pseudomonas aeruginosa.
Lagast H; Husson M; Klastersky J
J Antimicrob Chemother; 1985 May; 15(5):633-6. PubMed ID: 3924883
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo studies of three antibiotic combinations against gram-negative bacteria and Staphylococcus aureus.
Zinner SH; Klastersky J; Gaya H; Bernard C; Ryff JC
Antimicrob Agents Chemother; 1981 Oct; 20(4):463-9. PubMed ID: 6282192
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial activity of ciprofloxacin against Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus determined by the killing curve method: antibiotic comparisons and synergistic interactions.
Chalkley LJ; Koornhof HJ
Antimicrob Agents Chemother; 1985 Aug; 28(2):331-42. PubMed ID: 2939797
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of ciprofloxacin in combination with ceftazidime, aztreonam, and azlocillin against multiresistant isolates of Pseudomonas aeruginosa.
Bustamante CI; Wharton RC; Wade JC
Antimicrob Agents Chemother; 1990 Sep; 34(9):1814-5. PubMed ID: 2126693
[TBL] [Abstract][Full Text] [Related]
12. Comparison of ciprofloxacin with azlocillin plus tobramycin in the therapy of experimental Pseudomonas aeruginosa endocarditis.
Strunk RW; Gratz JC; Maserati R; Scheld WM
Antimicrob Agents Chemother; 1985 Sep; 28(3):428-32. PubMed ID: 2934021
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy of ciprofloxacin, azlocillin, and tobramycin alone and in combination in experimental Pseudomonas sepsis.
Johnson M; Miniter P; Andriole VT
J Infect Dis; 1987 Apr; 155(4):783-8. PubMed ID: 3102631
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Cobas Bact automated system for susceptibility testing of Enterobacteriaceae, Pseudomonas aeruginosa, and Enterococcus faecalis to azlocillin, mezlocillin, and ciprofloxacin compared to NCCLS and DIN standards.
Heizmann W; Werner H; Heilmann F
Infection; 1988; 16(1):63-8. PubMed ID: 3129374
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin.
Gilbert DN; Kohlhepp SJ; Slama KA; Grunkemeier G; Lewis G; Dworkin RJ; Slaughter SE; Leggett JE
Antimicrob Agents Chemother; 2001 Mar; 45(3):883-92. PubMed ID: 11181375
[TBL] [Abstract][Full Text] [Related]
16. [Antibacterial effects of the combinations of azlocillin with other antibiotics].
Courtieu AL; Billaudel S; Reynaud A; Drugeon HB
Presse Med; 1984 Mar; 13(13):785-7. PubMed ID: 6231595
[TBL] [Abstract][Full Text] [Related]
17. Synergy of imipenem--a novel carbapenem, and rifampin and ciprofloxacin against Pseudomonas aeruginosa, Serratia marcescens and Enterobacter species.
Chin NX; Neu HC
Chemotherapy; 1987; 33(3):183-8. PubMed ID: 3109815
[TBL] [Abstract][Full Text] [Related]
18. Effect of azlocillin and piperacillin in subinhibitory and inhibitory concentrations on Staphylococcus aureus and Pseudomonas aeruginosa in broth, in serum and in the presence of human polymorphonuclear leukocytes.
Bassler M; Depuis W; Utz E; Just HM; Daschner FD
Eur J Clin Microbiol; 1983 Oct; 2(5):439-44. PubMed ID: 6416838
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive evaluation of ciprofloxacin in combination with beta-lactam antibiotics against Enterobacteriaceae and Pseudomonas aeruginosa.
Haller I
Arzneimittelforschung; 1986 Feb; 36(2):226-9. PubMed ID: 2938593
[TBL] [Abstract][Full Text] [Related]
20. Serum bactericidal activity of ciprofloxacin and ofloxacin in volunteers.
Machka K; Milatovic D
Eur J Clin Microbiol; 1987 Feb; 6(1):59-62. PubMed ID: 3106034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
